Investigation Overview
April 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) was announced over potential breaches of fiduciary duties by certain officers and directors at Synergy Pharmaceuticals. The investigation by a law firm concerns whether certain Synergy Pharmaceuticals Inc officers and directors breached their fiduc...
You must register (for free) or login to view the entire investigation.